Research & Literature

Pathogenesis of Vertebral Anterior Wedge Deformity: A 2-Stage Process?

Landham PR, Gilbert SJ, Baker-Rand HL, et al.

Spine 2015; (40(12)):902-8 doi:10.1097/BRS.0000000000000905.

Management of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk.

Kenanidis E, Potoupnis ME, Kakoulidis P, et al.

Expert opinion on drug safety 2015; (14(7)):1035-53 doi:10.1517/14740338.2015.1040387.

SSRI use and risk of fractures among perimenopausal women without mental disorders.

Sheu YH, Lanteigne A, Stürmer T, et al.

Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention 2015; (21(6)):397-403 doi:10.1136/injuryprev-2014-041483.

Bone status in glucocorticoid-treated men and women.

Leib ES, Winzenrieth R

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2016; (27(1)):39-48 doi:10.1007/s00198-015-3211-1.

Epidemiology of Vertebral Fractures.

Schousboe JT

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2016; (19(1)):8-22.

The Vertebral Fracture Cascade: Etiology and Clinical Implications.

Broy SB

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2016; (19(1)):29-34.

Prediction of Incident Major Osteoporotic and Hip Fractures by Trabecular Bone Score (TBS) and Prevalent Radiographic Vertebral Fracture in Older Men.

Schousboe JT, Vo T, Taylor BC, et al.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2016; (31(3)):690-7 doi:10.1002/jbmr.2713.

Aromatase inhibitor treatment for breast cancer: short-term effect on bone health.

Erbağ G, Uygun K, Binnetoğlu E, et al.

Contemporary oncology (Poznan, Poland) 2015; (19(5)):374-7 doi:10.5114/wo.2014.45305.

Bisphosphonate Treatment in Osteoporosis: Optimal Duration of Therapy and the Incorporation of a Drug Holiday.

Villa JC, Gianakos A, Lane JM

HSS journal : the musculoskeletal journal of Hospital for Special Surgery 2016; (12(1)):66-73 doi:10.1007/s11420-015-9469-1.

AI-related BMD variation in actual practice conditions: A prospective cohort study.

Rodríguez-Sanz M, Prieto-Alhambra D, Servitja S, et al.

Endocrine-related cancer 2016; (23(4)):303-12 doi:10.1530/ERC-16-0025.

Diagnosis and Management of Vertebral Compression Fractures.

McCarthy J, Davis A

American family physician 2016; (94(1)):44-50.

Spine fracture prevalence in a nationally representative sample of US women and men aged ≥40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014.

Cosman F, Krege JH, Looker AC, et al.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2017; (28(6)):1857-1866 doi:10.1007/s00198-017-3948-9.

Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: The Denosumab and Teriparatide Follow-up study (DATA-Follow-up).

Leder BZ, Tsai JN, Jiang LA, Lee H

Bone 2017; (98()):54-58 doi:10.1016/j.bone.2017.03.006.

Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG.

Hadji P, Aapro MS, Body JJ, et al.

Journal of bone oncology 2017; (7()):1-12 doi:10.1016/j.jbo.2017.03.001.

Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS.

Tsourdi E, Langdahl B, Cohen-Solal M, et al.

Bone 2017; (105()):11-17 doi:10.1016/j.bone.2017.08.003.

The Trabecular Bone Score (TBS) Complements DXA and the FRAX as a Fracture Risk Assessment Tool in Routine Clinical Practice.

Hans D, Šteňová E, Lamy O

Current osteoporosis reports 2017; (15(6)):521-531 doi:10.1007/s11914-017-0410-z.

Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension.

Cummings SR, Ferrari S, Eastell R, et al.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2018; (33(2)):190-198 doi:10.1002/jbmr.3337.

Screening for Geriatric Syndromes: Falls, Urinary/Fecal Incontinence, and Osteoporosis.

Smith EM, Shah AA

Clinics in geriatric medicine 2018; (34(1)):55-67 doi:10.1016/j.cger.2017.08.002.

Red Flags for Low Back Pain Are Not Always Really Red: A Prospective Evaluation of the Clinical Utility of Commonly Used Screening Questions for Low Back Pain.

Premkumar A, Godfrey W, Gottschalk MB, Boden SD

The Journal of bone and joint surgery. American volume 2018; (100(5)):368-374 doi:10.2106/JBJS.17.00134.

Glucocorticoid-induced osteoporosis: an update.

Compston J

Endocrine 2018; (61(1)):7-16 doi:10.1007/s12020-018-1588-2.

Metastatic Spinal Cord Compression: Unraveling the Diagnostic and Therapeutic Challenges.

Boussios S, Cooke D, Hayward C, et al.

Anticancer research 2018; (38(9)):4987-4997 doi:10.21873/anticanres.12817.

Drug-induced bone loss: a major safety concern in Europe.

Nguyen KD, Bagheri B, Bagheri H

Expert opinion on drug safety 2018; (17(10)):1005-1014 doi:10.1080/14740338.2018.1524868.

Impact of prescription drugs on second fragility fractures among US Medicare patients.

Munson JC, Bynum JPW, Bell JE, et al.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2018; (29(12)):2771-2779 doi:10.1007/s00198-018-4697-0.

French recommendations for osteoporosis prevention and treatment in patients with prostate cancer treated by androgen deprivation.

Briot K, Paccou J, Beuzeboc P, et al.

Joint bone spine 2019; (86(1)):21-28 doi:10.1016/j.jbspin.2018.09.017.

Capture the vertebral fracture: Risk factors as a prediction.

Zvekic-Svorcan J, Aleksic J, Jankovic T, et al.

Journal of back and musculoskeletal rehabilitation 2019; (32(2)):269-276 doi:10.3233/BMR-170898.

New and emerging concepts in the use of denosumab for the treatment of osteoporosis.

Lewiecki EM

Therapeutic advances in musculoskeletal disease 2018; (10(11)):209-223 doi:10.1177/1759720X18805759.

Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis.

Park SY, Gong HS, Kim KM, et al.

Journal of bone metabolism 2018; (25(4)):195-211 doi:10.11005/jbm.2018.25.4.195.

Glucocorticoid-Induced Osteoporosis: New Insights into the Pathophysiology and Treatments.

Lane NE

Current osteoporosis reports 2019; (17(1)):1-7 doi:10.1007/s11914-019-00498-x.

The effects of adjuvant endocrine therapy on bone health in women with breast cancer.

Ramchand SK, Cheung YM, Yeo B, Grossmann M

The Journal of endocrinology 2019; (241(3)):R111-R124.

Proton Pump Inhibitors and Fracture Risk: A Review of Current Evidence and Mechanisms Involved.

Thong BKS, Ima-Nirwana S, Chin KY

International journal of environmental research and public health 2019; (16(9)) doi:10.3390/ijerph16091571.

MECHANISMS IN ENDOCRINOLOGY: Estradiol as a male hormone.

Russell N, Grossmann M

European journal of endocrinology 2019; (181(1)):R23-R43.

Assessment of early therapy discontinuation and health-related quality of life in breast cancer patients treated with aromatase inhibitors: B-ABLE cohort study.

Pineda-Moncusí M, Servitja S, Tusquets I, et al.

Breast cancer research and treatment 2019; (177(1)):53-60 doi:10.1007/s10549-019-05289-7.

An update on the problem of osteoporosis in people with epilepsy taking antiepileptic drugs.

Miziak B, Chrościńska-Krawczyk M, Czuczwar SJ

Expert opinion on drug safety 2019; (18(8)):679-689 doi:10.1080/14740338.2019.1625887.

Repeating Vertebral Fracture Assessment: 2019 ISCD Official Position.

Borges JLC, Sousa da Silva M, Ward RJ, et al.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2019; (22(4)):484-488 doi:10.1016/j.jocd.2019.07.005.

Repeating Measurement of Bone Mineral Density when Monitoring with Dual-energy X-ray Absorptiometry: 2019 ISCD Official Position.

Kendler DL, Compston J, Carey JJ, et al.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2019; (22(4)):489-500 doi:10.1016/j.jocd.2019.07.010.

Effects of a resistance and balance exercise programme on physical fitness, health-related quality of life and fear of falling in older women with osteoporosis and vertebral fracture: a randomized controlled trial.

Stanghelle B, Bentzen H, Giangregorio L, et al.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2020; (31(6)):1069-1078 doi:10.1007/s00198-019-05256-4.

Treatment options for glucocorticoid-induced osteoporosis.

Chiodini I, Merlotti D, Falchetti A, Gennari L

Expert opinion on pharmacotherapy 2020; (21(6)):721-732 doi:10.1080/14656566.2020.1721467.

Management manual for cancer treatment-induced bone loss (CTIBL): position statement of the JSBMR.

Fukumoto S, Soen S, Taguchi T, et al.

Journal of bone and mineral metabolism 2020; (38(2)):141-144 doi:10.1007/s00774-020-01087-0.

Pathophysiology of Bone Loss in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy and Lifestyle Modifications for the Management of Bone Health: A Comprehensive Review.

Kim TJ, Koo KC

Cancers 2020; (12(6)) doi:10.3390/cancers12061529.

Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosis.

Chiodini I, Falchetti A, Merlotti D, et al.

Expert review of endocrinology & metabolism 2020; (15(4)):283-298 doi:10.1080/17446651.2020.1772051.

Treatment of postmenopausal osteoporosis with bone-forming and antiresorptive treatments: Combined and sequential approaches.

Langdahl B

Bone 2020; (139()):115516 doi:10.1016/j.bone.2020.115516.

Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.

Black DM, Geiger EJ, Eastell R, et al.

The New England journal of medicine 2020; (383(8)):743-753 doi:10.1056/NEJMoa1916525.

A multiscale study of structural and compositional changes in a natural nanocomposite: Osteoporotic bone with chronic endogenous steroid excess.

Xi L, Zhang Y, Gupta H, et al.

Bone 2021; (143()):115666 doi:10.1016/j.bone.2020.115666.

Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS.

Tsourdi E, Zillikens MC, Meier C, et al.

The Journal of clinical endocrinology and metabolism 2020; doi:10.1210/clinem/dgaa756.

Patterns of Load-to-Strength Ratios Along the Spine in a Population-Based Cohort to Evaluate the Contribution of Spinal Loading to Vertebral Fractures.

Mokhtarzadeh H, Anderson DE, Allaire BT, Bouxsein ML

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2021; (36(4)):704-711 doi:10.1002/jbmr.4222.

Bone Mineral Density: Clinical Relevance and Quantitative Assessment.

Haseltine KN, Chukir T, Smith PJ, et al.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021; (62(4)):446-454 doi:10.2967/jnumed.120.256180.

Bisphosphonate Drug Holidays in Primary Care: When and What to Do Next?

Bauer DC, Abrahamsen B

Current osteoporosis reports 2021; (19(2)):182-188 doi:10.1007/s11914-021-00660-4.

High prevalence of vertebral fractures in seizure patients with normal bone density receiving chronic anti-epileptic drugs.

Dussault PM, McCarthy D, Davis SA, et al.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2021; (32(10)):2051-2059 doi:10.1007/s00198-021-05926-2.

Cancer Treatment-Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy.

Diana A, Carlino F, Giunta EF, et al.

Current treatment options in oncology 2021; (22(5)):45 doi:10.1007/s11864-021-00835-2.

Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer.

Waqas K, Lima Ferreira J, Tsourdi E, et al.

Journal of bone oncology 2021; (28()):100355 doi:10.1016/j.jbo.2021.100355.

Development of prediction model for osteoporotic vertebral compression fracture screening without using clinical risk factors, compared with FRAX and other previous models.

Chanplakorn P, Lertudomphonwanit T, Daraphongsataporn N, et al.

Archives of osteoporosis 2021; (16(1)):84 doi:10.1007/s11657-021-00957-y.

Understanding and Managing Corticosteroid-Induced Osteoporosis.

Kobza AO, Herman D, Papaioannou A, et al.

Open access rheumatology : research and reviews 2021; (13()):177-190 doi:10.2147/OARRR.S282606.

The Role of PINP in Diagnosis and Management of Metabolic Bone Disease.

Gillett MJ, Vasikaran SD, Inderjeeth CA

The Clinical biochemist. Reviews 2021; (42(1)):3-10 doi:10.33176/AACB-20-0001.

Fracture risk assessment by the FRAX model.

McCloskey EV, Harvey NC, Johansson H, et al.

Climacteric : the journal of the International Menopause Society 2022; (25(1)):22-28 doi:10.1080/13697137.2021.1945027.

Supervised exercise therapy compared with no exercise therapy to reverse debilitating effects of androgen deprivation therapy in patients with prostate cancer: a systematic review and meta-analysis.

Ussing A, Mikkelsen MK, Villumsen BR, et al.

Prostate cancer and prostatic diseases 2022; (25(3)):491-506 doi:10.1038/s41391-021-00450-0.

Multidisciplinary Consensus on the Prevention and Treatment of Osteoporosis and Fragility Fractures in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy.

Casado E, Borque-Fernando A, Caamaño M, et al.

The world journal of men's health 2022; (40(1)):74-86 doi:10.5534/wjmh.210061.

Romosozumab and antiresorptive treatment: the importance of treatment sequence.

Cosman F, Kendler DL, Langdahl BL, et al.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2022; (33(6)):1243-1256 doi:10.1007/s00198-021-06174-0.

Vitamin D Deficiency in Women with Breast Cancer: A Correlation with Osteoporosis? A Machine Learning Approach with Multiple Factor Analysis.

de Sire A, Gallelli L, Marotta N, et al.

Nutrients 2022; (14(8)) doi:10.3390/nu14081586.

Strong, steady and straight: UK consensus statement on physical activity and exercise for osteoporosis.

Brooke-Wavell K, Skelton DA, Barker KL, et al.

British journal of sports medicine 2022; (56(15)):837-846 doi:10.1136/bjsports-2021-104634.

Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club.

Laurent MR, Goemaere S, Verroken C, et al.

Frontiers in endocrinology 2022; (13()):908727 doi:10.3389/fendo.2022.908727.

Managements of osteoporotic vertebral compression fractures: A narrative review.

Patel D, Liu J, Ebraheim NA

World journal of orthopedics 2022; (13(6)):564-573 doi:10.5312/wjo.v13.i6.564.

Increased Risk of Fractures and Use of Proton Pump Inhibitors in Menopausal Women: A Systematic Review and Meta-Analysis.

da Maia TF, de Camargo BG, Pereira ME, et al.

International journal of environmental research and public health 2022; (19(20)) doi:10.3390/ijerph192013501.

The why and how of sequential and combination therapy in osteoporosis. A review of the current evidence.

Chandran M

Archives of endocrinology and metabolism 2022; (66(5)):724-738.

Denosumab Discontinuation.

Sølling AS, Tsourdi E, Harsløf T, Langdahl BL

Current osteoporosis reports 2023; (21(1)):95-103 doi:10.1007/s11914-022-00771-6.

Pathogenic mechanisms of glucocorticoid-induced osteoporosis.

Chen M, Fu W, Xu H, Liu CJ

Cytokine & growth factor reviews 2023; (70()):54-66 doi:10.1016/j.cytogfr.2023.03.002.

Effects of resistance and balance exercises for athletic ability and quality of life in people with osteoporotic vertebral fracture: Systematic review and meta-analysis of randomized control trials.

Li X, Chen W, Chen Q, et al.

Frontiers in medicine 2023; (10()):1135063 doi:10.3389/fmed.2023.1135063.

Musculoskeletal involvement: COVID-19 and post COVID 19.

Evcik D

Turkish journal of physical medicine and rehabilitation 2023; (69(1)):1-7 doi:10.5606/tftrd.2023.12521.

Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update.

Morin SN, Feldman S, Funnell L, et al.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2023; (195(39)):E1333-E1348 doi:10.1503/cmaj.221647.

2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.

Humphrey MB, Russell L, Danila MI, et al.

Arthritis & rheumatology (Hoboken, N.J.) 2023; (75(12)):2088-2102 doi:10.1002/art.42646.

2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.

Humphrey MB, Russell L, Danila MI, et al.

Arthritis care & research 2023; (75(12)):2405-2419 doi:10.1002/acr.25240.

Osseous implications of proton pump inhibitor therapy: An umbrella review.

Alanazi AS, Almutairi H, Gupta JK, et al.

Bone reports 2024; (20()):101741 doi:10.1016/j.bonr.2024.101741.

Aromatase Inhibitor-Associated Distal Radioulnar Joint Instability and Tear of the Extensor Digiti Minimi: A Case Report.

Holt J, Salas M, Lee SW

American journal of physical medicine & rehabilitation 2024; (103(7)):e86-e89 doi:10.1097/PHM.0000000000002456.

Thoracic Pyogenic Spondylitis Misdiagnosed As Osteoporotic Compression Fracture Status Post Vertebral Augmentation With Resultant Paraplegia: A Case Report.

Chen PW, Liu PC, Lee CC, Lam CT

Cureus 2024; (16(6)):e63497 doi:10.7759/cureus.63497.

Aromatase inhibitor-induced bone loss osteosarcopenia in older patients with breast cancer: effects of the RANK/RANKL system's inhibitor denosumab vs. bisphosphonates.

Casabella A, Paladin F, Bighin C, et al.

Internal and emergency medicine 2024; (19(8)):2193-2199 doi:10.1007/s11739-024-03725-1.

Medication-induced fractures: Screening and treatment strategies.

Javed L, Khakwani A, Khan U, Humphrey MB

The American journal of the medical sciences 2025; (369(1)):1-13 doi:10.1016/j.amjms.2024.08.024.

Safety of In-hospital Parenteral Antiosteoporosis Therapy Following a Hip Fracture: A Retrospective Cohort.

Abu-Jwead A, Fisher DL, Goldabart A, et al.

Journal of the Endocrine Society 2024; (8(11)):bvae172 doi:10.1210/jendso/bvae172.

Diagnosis and Management of Atypical Femoral Fractures and Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis.

Alnajmi RAY, Ali DS, Khan AA

Endocrinology and metabolism clinics of North America 2024; (53(4)):607-618 doi:10.1016/j.ecl.2024.08.007.

Prevention and treatment of glucocorticoid-induced osteoporosis in adults: recommendations from the European Calcified Tissue Society.

Paccou J, Yavropoulou MP, Naciu AM, et al.

European journal of endocrinology 2024; (191(6)):G1-G17 doi:10.1093/ejendo/lvae146.

Assessment and early investigation of cauda equina syndrome- a systematic review of existing international guidelines and summary of the current evidence.

Hennessy O, Devitt AT, Synnott K, Timlin M

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 2025; (34(4)):1545-1551 doi:10.1007/s00586-025-08732-0.

Probability of achieving bone mineral density treatment targets with abaloparatide and teriparatide.

Cosman F, Mitlak BH, Wang Y, et al.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2025; (40(6)):773-778 doi:10.1093/jbmr/zjaf053.

Bone Anabolic Treatment in Older Subjects: A Narrative Review.

Hadzimuratovic B, Mattes D, Haschka J, Kocijan R

Gerontology 2025; (71(10)):842-851 doi:10.1159/000547313.

Glucocorticoid-induced osteoporosis: novel concepts and clinical implications.

Hofbauer LC, Compston JE, Saag KG, et al.

The lancet. Diabetes & endocrinology 2025; (13(11)):964-979 doi:10.1016/S2213-8587(25)00251-7.

Making VFA Part of Standard Clinical DXA Assessment for Osteoporosis Care: Recommendations From the International Working Group on DXA Best Practices.

Lems WF, Ward KA, Lewiecki EM, et al.

Mayo Clinic proceedings 2025; (100(12)):2186-2205 doi:10.1016/j.mayocp.2025.08.005.

Drug-Induced Osteoporosis.

Gasser RW, Kocijan R, Zendeli A, Resch H

Journal of clinical medicine 2026; (15(3)) doi:10.3390/jcm15030993.

Bone health in patients with cancer: a SEOM-SEIOMM consensus review of risk factors, assessment strategies, and management approaches.

Beato-Zambrano C, Nogues X, Ramírez-Merino N, et al.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026; (28(8)):3059-3074 doi:10.1007/s12094-026-04256-1.

Mind the gap: Adherence to denosumab dosing and cessation guidelines in Australian residential aged care.

O'Donnell M, Westbrook JI, Rahman B, et al.

British journal of clinical pharmacology 2026; (92(8)):2819-2827 doi:10.1002/bcp.70574.

The Anabolic-First Strategy in Osteoporosis: A Systematic Review and Meta-Analysis of Fracture Outcomes in Patients at Very High Fracture Risk.

Cipolloni V, Bonifacio M, Hassny SM, et al.

Medicina (Kaunas, Lithuania) 2026; (62(4)) doi:10.3390/medicina62040687.

Indian Delphi consensus on cardiovascular risk mitigation in prostate cancer management.

Bakshi G, Lyon A, Joshi A, et al.

Frontiers in oncology 2026; (16()):1787811 doi:10.3389/fonc.2026.1787811.

Potent bisphosphonate therapy for preventing fractures after denosumab discontinuation in osteoporosis: A GRADE-assessed systematic review and meta-analysis.

Shah A, Khan S, Rizvi SVZ, et al.

Medicine 2026; (105(36)):e50542 doi:10.1097/MD.0000000000050542.

Cauda equina syndrome: a structured approach for the higher orthopaedic examination.

Pammi S, Rajan P, Narapareddy H

European journal of orthopaedic surgery & traumatology : orthopedie traumatologie 2026; (36(1)).

The Management of Pelvic and Vertebral Fragility Fractures: An Unmet Care Need.

Anderson PA, Giangregorio LM, Routt MLC

The Journal of bone and joint surgery. American volume 2026; doi:10.2106/JBJS.26.00966.